Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Vesalius Biocapital III Announces Final Close of EUR 120 Million Fund

Life sciences focused fund has executed three investments to date

Read more ››
By: PR Newswire Association LLC. - 25 Jun 2019

Natural Ferulic Acid Market Value to Hit $55 Million by 2025: Global Market Insights, Inc.

SELBYVILLE, Del., June 25, 2019 /PRNewswire/ -- Germany natural ferulic acid market size from functional food & dietary supplements applications is estimated to register over 5.5% gains by 2025 owing to significant preference for improving nutritional content of food products. This product... Read more ››

By: PR Newswire Association LLC. - 25 Jun 2019

Global Myelofibrosis Market 2017-2018 & 2019-2026: Celgene's $1.1bn Impact Buy is First of More Deals to Come in 2018 and Beyond

DUBLIN, June 25, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 25 Jun 2019

EpicentRx Announces Publication of Its Positive Phase 2 3rd Line SCLC Results With RRx-001 Plus a Platinum Doublet in the British Journal of Cancer (BJC)

LA JOLLA, Calif., June 25, 2019 /PRNewswire/ -- EpicentRx Inc., a clinical-stage immuno-oncology company with two platforms developed... Read more ››

By: PR Newswire Association LLC. - 25 Jun 2019
Related companies:  EpicentRx Inc.

Valley Home Care Averages 6.25% 30-day All-Cause Readmission Rate over 12-months

PARAMUS, N.J., June 25, 2019 /PRNewswire/ -- Valley Home Care has achieved a 6.25% 30-day all-cause hospital readmission rate over 12 months from January through December of 2018. Utilizing remote patient monitoring software from Health Recovery Solutions (HRS), Valley Home Care achieved monthly... Read more ››

By: PR Newswire Association LLC. - 25 Jun 2019

EMA Validates Santhera's Marketing Authorization Application for Puldysa® in Duchenne Muscular Dystrophy

Read more ››
By: Nasdaq / GlobenewsWire - 25 Jun 2019

Axiom Real-Time Metrics Exhibiting at DIA Global Annual Meeting in San Diego

Read more ››
By: Nasdaq / GlobenewsWire - 25 Jun 2019
Related companies:  Axiom Real-Time Metrics Inc.

PHASTAR Enters Technology Partnership With Medidata

Read more ››
By: Nasdaq / GlobenewsWire - 25 Jun 2019
Related companies:  Phastar | PHASTAR Inc.

Krystal Biotech Announces Pricing of $100.0 Million Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 25 Jun 2019
Related companies:  Krystal Biotech, Inc.

Stryker to host conference call on July 25, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Stryker Corporation

Vital® to focus on Enterprise Imaging and Encounters-Based Imaging Workflow Experience at SIIM 2019

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019

Immutep to Host Key Opinion Leader Call

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019

Cytokinetics Announces Preclinical Data for Reldesemtiv to be Presented at the 2019 Annual Cure SMA Conference

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Cytokinetics, Inc.

Eloxx Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Eloxx Pharmaceuticals, Inc.

Nabriva Therapeutics Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application for Lefamulin

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Nabriva Therapeutics plc

Conatus Announces Results from ENCORE-LF and ENCORE-PH Phase 2b Clinical Trials in NASH Cirrhosis

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Conatus Pharmaceuticals Inc.

Conatus to Explore Strategic Alternatives and Implement Restructuring Plan

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Conatus Pharmaceuticals Inc.

GENFIT: GENFIT and Terns Pharmaceuticals Announce $228MM Strategic Partnership to Develop and Commercialize Elafibranor in Greater China

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Genfit SA

Integra LifeSciences Announces Promotion of Glenn Coleman to Newly-Created Role of Chief Operating Officer and Appointment of Carrie Anderson as Chief Financial Officer

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Integra Lifesciences Holdings Corp

Agile Therapeutics Announces FDA Advisory Committee Meeting for its Investigational Transdermal Low-Dose Contraceptive Patch, Twirla® (AG200-15)

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Agile Therapeutics, Inc.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑